Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registry.

Benjamin, David J; Shrestha, Anshu; Fellman, Dimitra; Cress, Rosemary D; Lythgoe, Mark P; Rezazadeh Kalebasty, Arash

Benjamin, David J; Shrestha, Anshu; Fellman, Dimitra; Cress, Rosemary D; Lythgoe, Mark P; Rezazadeh Kalebasty, Arash.

Afiliação

Benjamin DJ; Hoag Family Cancer Institute, Newport Beach, CA, USA. David.Benjamin@hoag.org.
Shrestha A; Cancer Registry of Greater California (CRGC), Public Health Institute, Sacramento, CA, USA.
Fellman D; Cancer Registry of Greater California (CRGC), Public Health Institute, Sacramento, CA, USA.
Cress RD; Cancer Registry of Greater California (CRGC), Public Health Institute, Sacramento, CA, USA.
Lythgoe MP; Department of Public Health Sciences, University of California Davis, Davis, CA, USA.
Rezazadeh Kalebasty A; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.

Prostate Cancer Prostatic Dis ; 2023 Oct 05.

Article em En | MEDLINE | ID: mdl-37798437

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google